Diseases /

Small Intestinal Neuroendocrine Tumor

Back to Diseases List
Associated Genetic Biomarkers

Overview

NCI Definition: A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the small intestine. [1]

Small intestinal neuroendocrine tumors most frequently harbor alterations in CDKN1B, BCOR, POLQ, MEN1, and EP300 [2].

Most Commonly Altered Genes in Small Intestinal Neuroendocrine Tumor

BCOR Mutation, CDKN1fs, POLQ Mutation, SETD2 Mutation, and CDKN1B Mutation are the most common alterations in small intestinal neuroendocrine tumor [2].

Top Alterations in Small Intestinal Neuroendocrine Tumor

Biomarker-Directed Therapies

View Therapies for Small Intestinal Neuroendocrine Tumor

Clinical Trials

View Clinical Trials for Small Intestinal Neuroendocrine Tumor

Disease Details

Synonyms
Small Intestinal NET, Small Intestinal Well Differentiated Endocrine Tumor/Carcinoma, Small intestine neuroendocrine carcinoma, Small Intestinal Well Differentiated Endocrine Tumor
Parent(s)
Small Intestinal Neuroendocrine Neoplasm
Children
Jejunal Somatostatin-Producing Neuroendocrine Tumor, Duodenal Neuroendocrine Tumor, Small Intestinal VIP-Producing Neuroendocrine Tumor, and Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
OncoTree Name
Small Bowel Well-Differentiated Neuroendocrine Tumor
OncoTree Code
SBWDNET

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.